melanoma (skin)
Showing 51 - 75 of 328
Melanoma (Skin), Melanoma, Stage II Trial in Manchester (Nivolumab 10 MG/ML)
Recruiting
- Melanoma (Skin)
- Melanoma, Stage II
- Nivolumab 10 MG/ML
-
Manchester, Greater Manchester, United KingdomThe Christie NHS Foundation Trust
Nov 11, 2021
Reflectance Confocal Microscopy to Diagnose MM & LM
Completed
- Melanoma (Skin)
- Lentigo Maligna
- In-vivo imaging
-
London, United KingdomSkin Care Network Barnet Ltd
Nov 11, 2021
Melanoma (Skin), Squamous Cell Carcinoma of the Skin, Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (CV8102,
Active, not recruiting
- Melanoma (Skin)
- +3 more
- CV8102
- CV8102 + anti-PD-1 therapy
-
Graz, Austria
- +21 more
Nov 3, 2021
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
Melanoma (Skin), Moles Multiple Benign Trial in Headington (Total body photography)
Recruiting
- Melanoma (Skin)
- Moles Multiple Benign
- Total body photography
-
Headington, Oxford, United KingdomChurchill Hospital
Sep 21, 2021
Melanoma (Skin) Trial in New Brunswick, New York, Philadelphia (Nivolumab)
Active, not recruiting
- Melanoma (Skin)
- Nivolumab
-
New Brunswick, New Jersey
- +3 more
Sep 21, 2021
Melanoma (Skin) Trial in Cologne (MB-CART20.1)
Recruiting
- Melanoma (Skin)
- MB-CART20.1
-
Cologne, NRW, GermanyUniversity Hospital of Cologne - Clinic for Internal Medicine I
Sep 20, 2021
Skin Cancer, Melanoma (Skin) Trial in Melbourne (Molemap Skin Cancer Triage Artificial Intelligence Device)
Completed
- Skin Cancer
- Melanoma (Skin)
- Molemap Skin Cancer Triage Artificial Intelligence Device
-
Melbourne, Victoria, Australia
- +1 more
Aug 12, 2021
Melanoma and Non-melanoma Skin Cancer in People With Vitiligo
Active, not recruiting
- Vitiligo
- +5 more
- Exposure of skin cancer of interest
-
London, United KingdomMomentum Data Ltd
Jul 16, 2021
Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer Trial in United States (melphalan, regional chemo, systemic chemo)
Completed
- Intraocular Melanoma
- +2 more
- melphalan
- +3 more
-
Santa Monica, California
- +11 more
Jun 15, 2021
Melanoma (Skin) Trial in Philadelphia, Houston, Charlottesville (incomplete Freund's adjuvant, melanoma helper peptide vaccine,
Completed
- Melanoma (Skin)
- incomplete Freund's adjuvant
- +4 more
-
Philadelphia, Pennsylvania
- +2 more
Mar 25, 2021
Explore the Skin Microbes in Skin Cancer
Withdrawn
- Skin Cancer
- +4 more
- Non-interventional
-
Ventura, CaliforniaProgenaBiome
Apr 6, 2021
Melanoma (Skin) Trial in Newcastle, North Sydney, Sydney (Self-examination of the skin)
Completed
- Melanoma (Skin)
- Self-examination of the skin
-
Newcastle, New South Wales, Australia
- +2 more
Mar 11, 2021
Melanoma (Skin) Trial in Netherlands (nDC vaccination, injection)
Active, not recruiting
- Melanoma (Skin)
- nDC vaccination
- placebo injection
-
Amsterdam, Netherlands
- +4 more
Mar 11, 2021
Melanoma (Skin) Trial in La Jolla (recombinant interferon alfa-2b, azacitidine)
Completed
- Melanoma (Skin)
- recombinant interferon alfa-2b
- azacitidine
-
La Jolla, CaliforniaRebecca and John Moores UCSD Cancer Center
Mar 1, 2021
Ocular Tumors Based on New Artificial Intelligence Algorithm
Not yet recruiting
- Melanoma (Skin)
- +6 more
- (no location specified)
Jan 4, 2021
Educational Problems, Melanoma (Skin) Trial in Italy (Active educational intervention, Passive educational intervention)
Completed
- Educational Problems
- Melanoma (Skin)
- Active educational intervention
- Passive educational intervention
-
L'Aquila, AQ, Italy
- +6 more
Dec 1, 2020
Tissue Remodeling in Skin Using SFI (Skin Fluorescence Imaging)
Unknown status
- Skin Lesion
- +2 more
- Diagnostic Test
-
Fremont, California
- +6 more
Nov 17, 2020
Melanoma (Skin) Trial in Los Angeles (CP-675,206)
Completed
- Melanoma (Skin)
- CP-675,206
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Oct 1, 2020
Melanoma (Skin), Melanoma Stage IIIb-IVM1a, Metastasis Skin Trial in Cincinnati (Talimogene laherparepvec (T-Vec), Dabrafenib
Withdrawn
- Melanoma (Skin)
- +4 more
- Talimogene laherparepvec (T-Vec)
- +2 more
-
Cincinnati, OhioTriHealth Cancer Institute - Kenwood
Oct 14, 2020
Melanoma (Skin) Trial in Los Angeles (maximum tolerated dose of anti-cytotoxic T-lymphocyte-associated antigen-4 mAb)
Completed
- Melanoma (Skin)
- maximum tolerated dose of anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020
Melanoma (Skin) Trial in Los Angeles (dendritic cell-MART-1 peptide vaccine)
Completed
- Melanoma (Skin)
- dendritic cell-MART-1 peptide vaccine
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020
Melanoma (Skin) Trial in Shreveport (biological, drug, procedure)
Terminated
- Melanoma (Skin)
- filgrastim
- +5 more
-
Shreveport, LouisianaLouisiana State University School of Medicine
Jun 26, 2020
Melanoma (Skin) Trial in Changsha (Peptide, Anti-PD-1, rhGM-CSF)
Unknown status
- Melanoma (Skin)
- Peptide
- +3 more
-
Changsha, Hunan, ChinaXiangya Hospital, Central South University
Apr 24, 2020